Stock News

Pfizer (PFE): How It Could Double

Alexandros Michailidis/iStock Editorial via Getty Images I am maintaining a positive risk/reward rating on Pfizer (NYSE:PFE) based on its aggressive growth strategy, rapidly increasing growth estimates, a deeply discounted valuation, and unusually strong technical support. […]